Cutaneous Lichen Planus:
A Comprehensive Patient Guide
An Evidence-Based Guide to Understanding, Managing, and Living Well with Cutaneous Lichen Planus
Jump to a Section
Welcome
If you’ve recently been diagnosed with cutaneous lichen planus (lichen planus affecting the skin of the body), take a deep breath and let your shoulders drop.
You are in the right place, and we are happy you found us.
Cutaneous lichen planus (CLP) is a chronic, inflammatory, immune-mediated skin condition that commonly causes itchy, flat-topped bumps or patches on the skin. It is not contagious, and for many people it can be successfully managed with appropriate treatment. Many cases improve or resolve over time, although some people experience recurrent or more persistent disease [1, 2, 3, 4].
Whether you’ve arrived here after a recent diagnosis or you’re supporting someone you love, we hope this guide becomes a trusted source of information, reassurance, and hope. Please feel free to bookmark this page and return whenever you need answers, comfort, or a reminder that you are not navigating this journey alone.
Receiving a diagnosis of a chronic skin condition can feel overwhelming. Many people describe feeling anxious, isolated, frustrated, or uncertain about what comes next. Those feelings are completely understandable.
Cutaneous lichen planus affects far more than the skin itself. Because our skin is one of the first things the world sees, changes in its appearance can influence how we feel about ourselves, how we interact with others, what we wear, and even how confident we feel leaving the house. The emotional impact is real, and it deserves just as much attention as the physical symptoms.
This guide was created to provide evidence-based, patient-friendly education about every aspect of cutaneous lichen planus—from understanding how the disease develops to exploring treatments, self-care strategies, associated health conditions, and the latest research. Our goal is not simply to tell you what happens, but to help you understand why.
Because understanding your condition often makes it feel a little less frightening and, in time, can feel empowering.
Throughout this guide, you’ll notice medical terms followed by simple explanations. We believe patients deserve access to accurate medical information without needing a medical degree to understand it.
You don’t have to learn everything today.
If you want a simpler first-step roadmap before diving into this comprehensive guide, start with our newly diagnosed resource.
Start with the Newly Diagnosed Guide →Before We Begin
“Lichen planus” is actually an umbrella term for several related conditions that affect different parts of the body. This guide focuses specifically on cutaneous lichen planus, which affects the outer skin.
Other forms include:
Although these conditions share similar immune pathways, they often behave differently, require different treatments, and have unique long-term considerations. Over the coming months, aboutlichenplanus.com will publish comprehensive resources dedicated to each subtype. Until then, we encourage you to visit our comprehensive Lichen Planus Overview page to find information specific to your diagnosis.
Have symptoms in more than one part of your body?
The Comprehensive Lichen Planus Overview explains how LP can affect the skin, mouth, genitals, scalp, nails, and esophagus.
Explore the Comprehensive Lichen Planus Overview →Understanding Cutaneous Lichen Planus
What Is Cutaneous Lichen Planus?
Cutaneous lichen planus (CLP) is a chronic, inflammatory, immune-mediated skin disease that causes itchy, flat-topped bumps and patches to develop on the skin.
Let’s break that down:
Chronic
Chronic means it may last for months or sometimes years, although many people eventually experience remission [3].
Inflammatory
Inflammatory means your immune system is creating ongoing irritation within the skin, leading to skin color changes, itch, and changes in the skin’s appearance [2, 4].
Immune-Mediated
Immune-mediated means the immune system plays the central role in driving the disease [1]. While many experts consider lichen planus to have autoimmune features, researchers are still working to fully understand why the immune system begins targeting healthy skin in some people and not others [3, 4].
What’s Happening Under My Skin?

To understand cutaneous lichen planus, it helps to imagine your immune system as a highly trained neighborhood watch.
Under normal circumstances, this team constantly patrols your body, looking for genuine threats such as viruses, bacteria, or damaged cells. When it finds one, it sends in specialized immune cells to remove the danger before it can spread.
In cutaneous lichen planus, however, something goes wrong. Instead of identifying an actual threat, the immune system mistakenly sounds a false alarm.
Researchers have demonstrated that specialized immune cells called CD8+ cytotoxic T lymphocytes (a type of white blood cell responsible for destroying infected or abnormal cells) incorrectly identify healthy skin cells—specifically basal keratinocytes (the cells that sit at the deepest layer of the epidermis and continuously produce new skin)—as though they were dangerous invaders [1, 2, 3].
Once that false alarm is triggered, these immune cells gather along the junction where the outer and inner layers of the skin meet, releasing powerful inflammatory proteins known as cytokines (tiny messenger proteins that allow immune cells to communicate with one another) [2, 4].
Immune Cells
CD8+ cytotoxic T lymphocytes incorrectly identify healthy basal keratinocytes as targets.
Inflammatory Signals
Cytokines act as messenger proteins that recruit and activate additional immune cells.
One of the most important cytokines involved in cutaneous lichen planus is interferon-gamma (IFN-γ) [2, 5]. Think of interferon-gamma as a neighborhood emergency siren that never turns off. Instead of signaling that the danger has passed, it continues broadcasting distress messages that recruit more immune cells into the skin [5].
This creates a self-perpetuating cycle of inflammation. As more immune cells arrive, they release additional cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-2 (IL-2), and CXCL10, among others, which amplify the immune response even further [1, 2, 4]. Over time, this ongoing inflammation injures the basal layer of the skin, leading to the characteristic itchy, flat-topped, purple-red bumps that define cutaneous lichen planus [2, 3].
Why Did My Immune System Become Confused?
This is one of the biggest unanswered questions in lichen planus research. The honest answer is that we still don’t know exactly why the false alarm begins. And the truth is, the answer may differ from person to person, as this condition can be very individualized in terms of presentation, medication response, etc.
Current evidence suggests that lichen planus develops because multiple factors come together rather than one single cause [3]. Researchers believe the disease likely results from an interaction between:
- Genetic susceptibility (such as specific HLA gene pairings) [2]
- Immune system dysregulation [4]
- Environmental triggers [3]
- Infections (such as the Hepatitis C virus in certain populations–e.g., more common in Italy and Japan) [2, 3]
- Certain medications (leading to lichenoid drug eruptions). For example, common prescription drugs can trigger a lichenoid drug eruption (a skin reaction caused by a medicine that looks almost identical to spontaneous lichen planus). Common culprits include medications used to treat high blood pressure, such as beta-blockers and ACE inhibitors, as well as NSAIDs (non-steroidal anti-inflammatory drugs, such as ibuprofen). Finally, some cancer medications, such as immune checkpoint inhibitors (ICIs)—including ipilimumab, pembrolizumab, and nivolumab—can also cause a lichenoid drug eruption. In these situations, the rash often improves once the medication is safely changed or discontinued.
- Physical skin injury (known as the Koebner phenomenon) [1, 3]
- Significant psychological or physical stress [3]
Always make these changes under strict medical supervision, as stopping heart or blood pressure medications abruptly can be dangerous. [1]
In other words, you may think of it as a “perfect storm.” One factor alone is usually not enough. Instead, several pieces appear to come together before the immune system mistakenly begins attacking healthy skin.

AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
The good news is that although researchers are still uncovering exactly why this process begins, they now understand far more about how it unfolds. That growing knowledge has already led to better treatments and is driving exciting research into targeted therapies designed to interrupt the immune pathways responsible for lichen planus [1].
Key Takeaways
- Cutaneous lichen planus is a chronic, immune-mediated inflammatory skin disease [2, 3].
- It is not contagious, and you cannot spread it to anyone else [2].
- The condition develops when the immune system mistakenly attacks healthy cells at the base of the skin [3, 5].
- Scientists believe lichen planus results from a combination of genetics, immune dysregulation, and environmental triggers, rather than a single cause [2, 3].
- Researchers continue to identify new immune pathways involved in lichen planus, creating opportunities for more targeted treatments in the future [1, 4].
Systemic Health and Autoimmune Connections
One of the most important things researchers have learned over the past two decades is that cutaneous lichen planus is more than a skin condition. While its most visible symptoms appear on the skin, the inflammation driving the disease may also be associated with changes elsewhere in the body.
It is important to remember that these are associations, not guarantees. Having cutaneous lichen planus does not mean you will develop these conditions. Rather, studies have shown that some health conditions occur more frequently in people living with CLP than they do in the general population. Understanding these connections simply helps you and your healthcare team take a more proactive approach to your overall health.
Metabolic Health: Looking Beyond the Skin
One of the most consistent findings in the medical literature is that people with cutaneous lichen planus have a higher prevalence of metabolic conditions, which are health conditions that affect how your body processes fats, sugars, and energy [6, 7].
Compared with the general population, people living with CLP are more likely to have:
Why Are These Conditions Connected?
Scientists are still working to fully understand these relationships, but one leading theory involves chronic systemic inflammation [7, 11].
Although you may only notice symptoms on your skin, the immune cells responsible for cutaneous lichen planus don’t work in isolation. The same inflammatory messengers (those darn cytokines) that contribute to the itchy bumps and rash also circulate throughout the bloodstream [10]. Researchers believe these inflammatory signals may influence how the liver processes cholesterol, how blood vessels function, and how the body regulates blood sugar and metabolism [7]. Of course, this has not been definitively proven and is a theory.
This doesn’t mean that cutaneous lichen planus directly causes high cholesterol or diabetes. Instead, it suggests that shared inflammatory pathways may contribute to both conditions.
Because of these findings, many experts recommend discussing baseline blood work with your primary care provider or general physician when you are first diagnosed with cutaneous lichen planus [6].

Baseline Health Checks to Discuss With Your Provider
This may include:
- A fasting lipid panel (cholesterol) [6, 7]
- Blood glucose or HbA1c (blood sugar) [6, 9]
- Blood pressure monitoring [6, 8]
These simple tests can help identify potential health concerns early, often before symptoms develop. You may ask your primary care physician (PCP), general physician (GP), or your family doctor to run them.
Want to Make an Impact on Cutaneous Lichen Planus Research and Treatment?
Your experience matters. If you are 18+ and living in the United States with lichen planus affecting the skin, mouth, or genital area, take our survey and help researchers better understand barriers to care, treatment, and research participation.
Thyroid Disease and Other Autoimmune Conditions
Another well-recognized association involves the thyroid gland.
Cutaneous lichen planus is considered an immune-mediated disease, meaning the immune system plays a central role in its development [2, 11]. Because of this, some people with CLP are also more likely to have other immune-mediated or autoimmune conditions, particularly hypothyroidism, where the thyroid gland does not produce enough thyroid hormone to regulate the body’s metabolism [12].
Rather than representing two completely unrelated illnesses, both conditions may reflect an immune system that has become more likely to mistakenly recognize healthy tissues as targets [3, 12].
Researchers continue to study whether cutaneous lichen planus is also associated with other autoimmune conditions, but thyroid disease remains one of the most consistently reported findings across large observational studies and pooled global analyses [12].
For this reason, many clinicians consider obtaining a baseline thyroid panel. When discussing this with your healthcare provider, a comprehensive initial assessment typically evaluates:
- Thyroid-Stimulating Hormone (TSH): The primary screening test used to evaluate overall thyroid function and determine if the thyroid is underactive or overactive.
- Free Thyroxine (Free T4): Measures the actual amount of active, unbound thyroid hormone circulating in your blood.
- Thyroid Peroxidase Antibodies (TPOAb): A crucial blood test to check for autoimmune thyroid disease (such as Hashimoto’s thyroiditis), which helps determine if an underlying autoimmune flare is driving the thyroid dysfunction.
Requesting these baseline tests is particularly important if someone has symptoms such as:
- persistent fatigue
- constipation
- feeling unusually cold
- unexplained weight changes
- dry skin
- hair thinning
or a personal or family history of thyroid disease [12].
Looking After Your Whole Health
The goal of understanding these associations is not to create worry; it is to create opportunity. By recognizing these connections early, your healthcare team can monitor your overall health, identify potential concerns sooner, and treat them before they become more significant problems.
Think of cutaneous lichen planus as one piece of your health story, not the whole story. Working closely with your dermatologist, primary care provider, and other healthcare professionals allows you to care for your skin while also supporting your long-term cardiovascular, metabolic, and endocrine health.
A Message of Hope
Receiving a diagnosis of cutaneous lichen planus can feel frightening, especially when you begin reading about inflammation and immune system changes. However, there is encouraging news.
For most people, classic cutaneous lichen planus is a self-limited disease. Many cases gradually improve over 12 to 18 months, and with appropriate treatment, symptoms often become much more manageable [3]. Some people experience complete remission, while others may have occasional flares or a more prolonged course, particularly with certain subtypes such as hypertrophic lichen planus [1, 2].
Perhaps most importantly, researchers continue to make significant progress in understanding the immune pathways involved in lichen planus [10]. This growing knowledge has already led to more targeted therapies and continues to drive exciting research into new treatments that aim to interrupt the disease process more precisely than ever before [1].
With the right medical care, regular follow-up, and evidence-based treatment, the vast majority of people with cutaneous lichen planus are able to successfully manage their condition and maintain an excellent quality of life.
Key Takeaways
- Cutaneous lichen planus affects more than the skin and has been associated with several metabolic and autoimmune conditions [6, 12].
- People with CLP are more likely to have metabolic syndrome, abnormal cholesterol, type 2 diabetes, and hypothyroidism than the general population, although these conditions do not develop in everyone [6, 7, 8, 9, 12].
- Researchers believe these associations are related to shared inflammatory and immune pathways rather than CLP directly causing these diseases [7, 11].
- Routine baseline blood work—including cholesterol, blood sugar, and, when appropriate, thyroid function testing—may help identify associated conditions early [6, 12].
- Most cases of classic cutaneous lichen planus improve over time, and ongoing research continues to expand treatment options and improve patient outcomes [1, 3].
Does Cutaneous Lichen Planus Increase My Risk of Skin Cancer?
One of the most common (and completely understandable) questions people ask after being diagnosed with cutaneous lichen planus is: “Does this increase my risk of skin cancer?”
Fortunately, for classic cutaneous lichen planus, the answer is very reassuring.
Current evidence shows that classic cutaneous lichen planus affecting the outer skin carries an extremely low risk of becoming cancerous. Unlike oral or vulvovaginal lichen planus, where long-term monitoring is recommended because of a small but recognized increased risk of squamous cell carcinoma, the vast majority of cutaneous lichen planus lesions remain completely benign (non-cancerous) throughout their course [1, 2, 11].
Researchers believe that chronic inflammation can, in some circumstances, alter how cells grow over many years [1]. However, when scientists have examined large groups of patients with classic cutaneous lichen planus, they have found that malignant transformation is exceptionally rare [2, 11, 32].
A Small Exception: Hypertrophic Lichen Planus
There is one important exception worth mentioning.
A less common subtype called hypertrophic lichen planus causes thick, rough, intensely itchy plaques, most often on the lower legs or shins. These plaques can persist for many years and may be more difficult to treat than classic lichen planus.
Although still uncommon, a very small number of long-standing hypertrophic lesions have been reported to develop squamous cell carcinoma, a type of skin cancer that arises from the outer layers of the skin [1, 2]. Fortunately, these cases remain rare, and they almost always occur in lesions that have been chronically inflamed for many years, rather than in newly diagnosed or appropriately treated disease [1, 12]. For hypertrophic lesions, injections of cortisone or triamcinolone into the lesions or taking oral hydroxychloroquine can help melt away the lesions.
Protecting Your Skin
The good news is that you have a great deal of control over minimizing this already small risk. By:
- following your dermatologist’s treatment plan,
- reducing ongoing inflammation,
- attending routine follow-up appointments,
- and reporting any lesion that changes significantly, refuses to heal, begins bleeding, ulcerates, or grows rapidly,
you help keep your skin healthy and allow any concerning changes to be assessed promptly.
For the overwhelming majority of people living with classic cutaneous lichen planus, skin cancer is not something that should cause ongoing worry. Instead, your focus should remain on controlling inflammation, protecting your skin barrier, and maintaining regular dermatologic care.
Is Cutaneous Lichen Planus Contagious? Can It Spread?
If you’ve recently been diagnosed with cutaneous lichen planus, you may find yourself wondering: “Can I give this to someone else?” or “Am I accidentally spreading it around my own body?”
The answer to both questions is no.
You Cannot Give Cutaneous Lichen Planus to Anyone Else
Cutaneous lichen planus is not contagious [2]. You cannot pass it to your partner, children, family members, friends, coworkers, or anyone else through:
- touching or hugging
- kissing
- sharing towels
- sharing clothing
- swimming pools or hot tubs
- toilet seats
- sexual contact
Unlike infections caused by bacteria, viruses, or fungi, cutaneous lichen planus develops because your own immune system mistakenly targets healthy skin cells [1, 2]. Since there is no infectious organism causing the disease, there is nothing for another person to “catch.”
Can It Spread Around My Own Body?
This is another common misconception. Although new spots may appear over time, you are not spreading the rash by touching it.
For example, if you have lichen planus on your leg and then touch your arm, the bumps will not transfer to your arm the way poison ivy, ringworm, or another infectious rash might. Instead, new lesions develop because your immune system becomes active in another area of skin, not because you physically moved the disease from one location to another [1].
Sometimes this can happen through a process called the Koebner phenomenon, where new lesions develop in areas of skin that have experienced injury or repeated irritation [2, 13]. Common triggers include:
- scratching
- persistent rubbing
- friction from tight clothing
- cuts or scrapes
- surgical scars
- sunburn
- tattoos in susceptible individuals
This doesn’t mean the rash is contagious—it simply reflects an immune system that is unusually responsive to skin injury [13].

AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
Why It Matters
Understanding this distinction is important because many people become afraid to touch their skin or worry about infecting loved ones. You don’t need to isolate yourself, avoid hugs, or worry about everyday contact.
Instead, the goal is to protect your skin from unnecessary trauma. Keeping itching under control, avoiding vigorous scratching when possible, moisturizing regularly, and reducing friction can all help decrease the likelihood of new lesions developing through the Koebner phenomenon.
Want to Make an Impact on Cutaneous Lichen Planus Research and Treatment?
Your experience matters. If you are 18+ and living in the United States with lichen planus affecting the skin, mouth, or genital area, take our survey and help researchers better understand barriers to care, treatment, and research participation.
Cutaneous Lichen Planus Signs and Symptoms: What Your Skin May Be Telling You
Cutaneous lichen planus, sometimes shortened to CLP, is an inflammatory condition that affects the skin. Its appearance and symptoms can vary considerably from one person to another.
Some people develop a small number of mildly itchy bumps. Others experience widespread lesions, intense itching, sleep disruption, skin tenderness, or lasting pigment changes. This variation is one reason cutaneous lichen planus can sometimes be mistaken for eczema, psoriasis, a medication reaction, or another inflammatory skin condition.[1, 14, 15]
What Is the Difference Between a Sign and a Symptom?
Symptoms
Symptoms are sensations or changes that you notice and report, such as itching, burning, soreness, or interrupted sleep. These are things we feel in our bodies, even though they cannot be observed visually. For example, you cannot see itch on a person. You may be able to infer someone has itchy skin if you can see scratch marks, but you cannot physically see the itch itself.
Clinical Signs
Clinical signs are changes a person can observe with their eyes (or with the aid of medical magnifying equipment), such as the shape, color, distribution, and surface pattern of the lesions. For example, you cannot feel redness, but you can visually see it on your skin.
Both matter. Your healthcare professional can see the rash, but only you can explain how it feels and how it affects your daily life.
Common Symptoms of Cutaneous Lichen Planus
Itching
Itching (medically called pruritus) is one of the most characteristic symptoms of classic cutaneous lichen planus.[1, 14, 15]
The intensity varies. It may feel like:
- a persistent itch that is difficult to ignore;
- a burning or prickling sensation;
- an urge to scratch that becomes worse at night; or
- an itch severe enough to interfere with sleep, concentration, work, or relaxation.
However, not every person with cutaneous lichen planus experiences severe itching. Some lesions cause only mild discomfort, while others may be relatively asymptomatic (in other words, you do not feel anything). [1, 14]
Repeated scratching or rubbing may further irritate the skin and can make affected areas thicker. It may also increase the likelihood of lingering color changes after the inflammation settles.
Tenderness, Burning, or Soreness
Some areas may feel tender, irritated, or sore, particularly if the skin has been scratched, rubbed by clothing, or affected by thicker plaques. Pain is not usually the defining symptom of classic cutaneous lichen planus, but discomfort can occur depending on the location and severity of the inflammation.[1, 14]
Tell your healthcare professional when lesions are painful, blistering, rapidly changing, draining, or developing open areas. These features may require closer assessment because they are not typical of every form of cutaneous lichen planus.
The Traditional “Six Ps” of Cutaneous Lichen Planus
Healthcare professionals are often taught to recognize classic cutaneous lichen planus through a group of features known as the six Ps [1, 14, 15]. They may use something called a dermatoscope to better see the details of the skin.
- 1. Pruritic The lesions are often itchy. The degree of itching can range from mild to severe.
- 2. Polygonal Individual bumps may have angular or many-sided borders rather than appearing perfectly round. Think of a polygon drawn in geometry class (oh, nostalgia): its edges meet at small angles instead of forming a smooth circle.
- 3. Planar The bumps usually have relatively flat tops rather than pointed or dome-shaped surfaces.
- 4. Purple On lighter skin, active lesions are traditionally described as purple, violet, or violaceous. However, color alone should never be used to diagnose or exclude cutaneous lichen planus.
- 5. Papules and Plaques A papule is a small, raised bump. Several papules may gather together and merge into a larger raised area called a plaque.
- 6. Wickham Striae Wickham striae are fine white or grey-white lines that may cross the surface of a lesion in a delicate, lacy, or web-like pattern.

AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
Wickham striae may be difficult to see with the naked eye. A dermatologist may make them easier to identify by examining the skin with a dermatoscope, a handheld magnifying instrument with specialized lighting. Wickham striae are a helpful diagnostic clue, but they are not equally visible in every lesion or every subtype of lichen planus.[1, 14, 15, 16]
Where Does Cutaneous Lichen Planus Commonly Appear?
Classic cutaneous lichen planus frequently affects:
- the inner, or flexor, surfaces of the wrists;
- the forearms;
- the ankles;
- the shins;
- the lower back; and
- the trunk.[1, 14, 15]
The lesions may appear on both sides of the body, but their distribution is not always perfectly symmetrical.
Lichen planus can also affect the mouth, genitals, scalp, hair follicles, and nails. These forms may look and behave differently from classic cutaneous lichen planus and may require different examinations, monitoring, and treatment approaches.[1, 14, 15]
Tell your healthcare professional about symptoms elsewhere on your body, including:
- mouth soreness or white patches;
- vulvar, vaginal, penile, or perianal symptoms;
- scalp tenderness, scaling, or hair loss; and
- nail thinning, splitting, ridging, or scarring.
Your skin may not be the only place LP appears.
Use the full LP Overview to compare site-based subtypes. If you also have vulvar symptoms and are trying to understand the difference between lichen planus and lichen sclerosus, we also have a side-by-side guide.
Explore Other Lichen Planus Subtypes →Compare Vulvar Lichen Planus and Lichen Sclerosus →
Cutaneous Lichen Planus in Skin of Colour
The traditional description of lichen planus as a “purple rash” was largely developed from observations of lighter skin. It does not fully describe how inflammation may appear across the complete range of skin tones.
In brown and black skin, active lesions may appear:
- violet or deeply violaceous;
- grey or grey-brown;
- dark brown;
- darker than the surrounding skin; or
- less visibly red than inflammatory lesions on lighter skin.[14, 15, 17]
The contrast between the lesion and surrounding skin may also be subtle. For this reason, healthcare professionals should evaluate more than color. Shape, texture, distribution, symptoms, surface markings, and dermoscopic findings may provide equally important clues.
Post-Inflammatory Hyperpigmentation
After active lesions flatten, they commonly leave behind post-inflammatory hyperpigmentation, meaning darker marks remain where inflammation previously occurred.[1, 14, 15]
An analogy is a footprint left after someone steps in soft ground: the active inflammation may be gone, but a visible trace remains.
These marks do not necessarily mean that cutaneous lichen planus is still active. However, pigment changes may persist for months or longer and may be especially noticeable or prolonged in people with more melanin-rich skin.
If you are uncertain whether a spot represents active inflammation or a residual pigment change, ask your dermatologist before changing or stopping treatment.
How Cutaneous Lichen Planus Is Diagnosed
There is no single blood test that confirms classic cutaneous lichen planus. Diagnosis usually begins with a detailed medical history and a careful examination of the skin.[1, 14, 15]
In some people, the appearance and distribution are characteristic enough for a clinician to make a clinical diagnosis. In other cases, a skin biopsy may be recommended to support the diagnosis and rule out conditions that can look similar.[1, 14, 15, 18]
Lichen planus is frequently confused with other conditions.
If your path to diagnosis has included eczema, psoriasis, medication reactions, or conflicting answers, our diagnostic-delay guide explains why LP can be difficult to identify.
Read Why People With LP Are Often Misdiagnosed First →
AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
Step 1: Your First Healthcare Appointment
Your assessment may begin with a family physician, primary care clinician, nurse practitioner, or dermatologist. Who you see first will depend on your healthcare system, access to specialists, and the complexity of your symptoms.
A primary care clinician may recognize classic cutaneous lichen planus and begin treatment. Referral to a dermatologist may be especially helpful when:
- the diagnosis is uncertain;
- the rash is widespread or severe;
- initial treatment is not working;
- the scalp, nails, mouth, or genital area may be involved;
- lesions are blistering, ulcerated, or otherwise atypical; or
- a biopsy or specialized treatment is being considered.[1, 14, 15]
Prepare before you walk into the room.
Use the interactive Appointment Planner to organize symptoms, medication changes, questions, and the details you want your healthcare team to know.
Open the Free Appointment Planner →Preparing for the Appointment: Create a Skin Diary
A short skin diary can help your healthcare professional understand how the condition has developed.
Record:
- when the first lesion appeared;
- where it appeared;
- whether the rash has spread;
- how the itching or discomfort has changed;
- whether symptoms interfere with sleep;
- treatments you have already tried; and
- anything that seemed to occur shortly before the rash began.
You may also take clear photographs every few days using similar lighting and distance. Photographs can help document changes, particularly when lesions fade, flare, or change before your appointment. The number of times I (Jaclyn) have had a bruise, skin color change that disappears before I finally get in to see the doctor is just wild! I’ve learned to take photographs in advance just in case; at least it gives something for the healthcare provider to work with.
Bring a Complete Medication List
Bring a current list of:
- prescription medications;
- non-prescription medications;
- vitamins;
- herbal and homeopathic products; and
- dietary supplements.
Certain medications can cause lichenoid drug eruptions. These are rashes that resemble lichen planus clinically or under the microscope.[1, 14, 15] If you know when the medications were started, note that down; but do not stress if you do not recall (I rarely remember).
This does not mean you should stop taking the medication on your own. Some reactions can occur months after a medication was started, and deciding whether a drug is involved requires careful review of the timing, appearance, and medical necessity of the medication.

What the Clinician May Examine
A healthcare professional may ask to examine more than the first area where the rash appeared. Depending on your symptoms, the assessment may include:
- the skin across different body areas;
- the scalp;
- the fingernails and toenails;
- the inside of the mouth; and
- genital skin, with your consent.
This is because lichen planus can affect more than one body site at the same time[1, 14, 15].
You remain in control of the examination. You can ask why a particular area needs to be examined, request a chaperone, ask the clinician to pause, or decline any part of the examination.
When Is a Skin Biopsy Needed?
A biopsy is not required in every case of cutaneous lichen planus.
A clinician may recommend one when:
- the lesions do not have a classic appearance;
- another condition must be ruled out;
- the rash may be medication-related;
- the condition is not responding as expected;
- the lesions have unusual, blistering, erosive, or ulcerated features; or
- confirming the diagnosis would change the treatment plan.[1, 14, 15, 18]
A biopsy does not always provide a completely definitive answer by itself. The pathologist’s findings must be interpreted together with the appearance of the rash, the symptoms, the medication history, and the areas of the body involved.
Choosing the Biopsy Site
The clinician usually selects a well-developed, representative lesion that has not been heavily scratched or altered by infection.
Biopsy-site selection matters. It is a little like trying to identify a plant from one leaf: the sample is most useful when the leaf still contains the features that distinguish the plant from similar species.
Using topical corticosteroids on a lesion before the biopsy can sometimes reduce visible inflammation under the microscope. Do not stop prescribed treatment without medical advice, but tell the clinician what has been applied to the proposed biopsy site and when it was last used as this can possibly affect the accuracy of the result.[18]
What Type of Skin Biopsy Is Commonly Used?
Punch Biopsy
A punch biopsy is commonly used when cutaneous lichen planus requires histologic confirmation.[14, 18]
After numbing the skin, the clinician uses a small circular instrument to remove a narrow cylinder of tissue. The tool is sometimes compared to a miniature cookie cutter, although it is designed specifically for medical use.
A punch biopsy captures the epidermis and part of the deeper dermis. This is useful because lichen planus is an interface dermatitis: many of its characteristic microscopic changes occur around the boundary between the outer skin layer and the tissue beneath it.[14, 18]
Depending on the size and location, the biopsy site may be closed with one or more stitches. Very small sites may occasionally be left to heal without stitches.
Is a Shave Biopsy Used?
A shave biopsy removes a more superficial layer of skin. It is useful for many raised skin growths, but it may not always capture enough depth to assess an inflammatory interface condition such as lichen planus.
For this reason, a punch biopsy is often preferred when the purpose is to confirm suspected cutaneous lichen planus. [18]
Ultimately, either shave or punch can work; it depends on how the skin looks and what the clinician thinks after a physical exam. [18] You can always inquire why they are choosing one type over the other.
What Happens During a Skin Biopsy?
Before the Procedure
Most routine skin biopsies do not require fasting or extensive preparation.
Tell the healthcare team if you:
- take anticoagulants (e.g., warfarin (Coumadin), apixaban (Eliquis), antiplatelet drugs e.g., aspirin (ASA), clopidogrel (Plavix), or other medications that affect bleeding (e.g., ibuprofen, naproxen etc). Examples are not exhaustive; if you aren’t sure, mention it.
- have a bleeding disorder;
- have an allergy or previous reaction to local anesthetic, adhesive, antiseptic, or medical tape;
- have a pacemaker or implanted medical device, if electrosurgery may be used;
- tend to faint during needles or medical procedures; or
- have previously developed thick or raised scars.
Do not stop a prescribed blood thinner unless the clinician who manages it tells you to do so.
During the Procedure
The skin is cleaned, and a local anesthetic, often lidocaine, is injected around or beneath the biopsy site.
The injection may cause a brief pinch, pressure, or burning sensation. Once the area is numb, you should not feel sharp pain during the biopsy, although you may notice pressure, movement, or pulling.
That said, we all experience pain and discomfort differently. Tell the clinician immediately if you feel pain; more anesthetic can often be provided.
If procedures make you anxious, it may help to:
- tell the clinician before they begin;
- ask to lie down;
- look away from the equipment;
- plug in (literally, put some earbuds in and listen to a guided meditation or your favorite song);
- take slow breaths with a longer exhale; or
- ask the clinician to explain each step—or, if you prefer, not describe it.
After the Procedure
The clinician will control any bleeding and cover the site with a dressing. If stitches were used, you will be told when and where they should be removed.
Mild soreness, sensitivity, bruising, or a small amount of spotting on the dressing may occur after the anesthetic wears off.

Caring for the Biopsy Site
Biopsy aftercare varies according to the site, biopsy depth, dressing, and whether stitches were placed. Always follow the instructions supplied by your own clinic, even when they differ from general online advice.
- Leave the original dressing in place for the period recommended by your clinician.
- Wash your hands before touching the wound.
- Gently clean the area with mild soap and water once permitted.
- Pat the area dry rather than rubbing it.
- Apply a thin layer of plain petroleum jelly if recommended.
- Cover the site with a clean dressing and change it as instructed.
- Avoid picking at the wound or removing a scab.
- Avoid swimming, hot tubs, and prolonged soaking until the site has adequately closed and your clinician says these activities are safe.
Routine use of an over-the-counter antibiotic ointment is not necessary for every clean biopsy wound and can occasionally cause allergic contact dermatitis. Use it only when your healthcare professional specifically recommends it.[18]
When to Contact the Clinic
Seek medical advice if you develop:
- bleeding that does not stop after firm, continuous pressure;
- increasing redness, warmth, swelling, or pain;
- pus or foul-smelling drainage;
- fever;
- red streaking away from the wound;
- separation of the wound edges; or
- an allergic reaction to the dressing or adhesive.
For urgent or rapidly worsening symptoms, follow your local urgent-care or emergency instructions.
Understanding Your Biopsy Results
The tissue sample is sent to a pathology laboratory. A dermatopathologist or pathologist examines very thin, specially stained sections of the tissue under a microscope.
In classic cutaneous lichen planus, the pathologist may identify a characteristic pattern of inflammation where the epidermis meets the dermis. Findings can include a dense, band-like collection of immune cells, injury to basal keratinocytes, and changes in the shape and thickness of the epidermis.[14, 15]
These findings help support the diagnosis, but several other inflammatory or medication-related conditions can create a lichenoid pattern. For that reason, the pathology report must be matched with the clinical examination and medical history.
How Long Do Results Take?
Turnaround time varies among clinics and laboratories. Some results return within several days, while others take longer because:
- additional tissue sections or stains are needed;
- the findings require specialist review;
- the sample is sent to another laboratory; or
- the clinical and microscopic and/or the results from the physical exam and tests need to be investigated further.
Before leaving the clinic, ask:
- how results will be communicated;
- approximately when you should expect them;
- whom to contact if you have not received them; and
- whether a follow-up appointment is required.
Can Treatment Begin Before the Results Return?
Sometimes a clinician begins treatment at the first visit when the clinical suspicion is strong and symptoms are significantly affecting the patient.
In other situations, the clinician may prefer to wait for the pathology report, particularly when the diagnosis is uncertain or when the possible treatments differ substantially.
Starting or delaying treatment is an individualized medical decision. Ask your clinician what they suspect, what the biopsy is intended to clarify, and what you can safely do for symptom relief while waiting.
Key Takeaway
Cutaneous lichen planus does not look or feel exactly the same in everyone. Itching is common, but its intensity varies. Lesions may appear purple on lighter skin, but may look violet, grey-brown, dark brown, or hyperpigmented in more melanin-rich skin.
Some cases can be diagnosed from their clinical appearance. Others require a biopsy to distinguish cutaneous lichen planus from eczema, psoriasis, medication-related lichenoid eruptions, and other inflammatory skin diseases.
You do not need to memorize the “six Ps” or interpret your skin alone. Your most important role is to document what you notice, explain how the condition affects you, and work with a qualified healthcare professional to obtain an accurate diagnosis and an individualized treatment plan.
Want to Make an Impact on Cutaneous Lichen Planus Research and Treatment?
Your experience matters. If you are 18+ and living in the United States with lichen planus affecting the skin, mouth, or genital area, take our survey and help researchers better understand barriers to care, treatment, and research participation.
The Treatment Landscape: Evidence, Side Effects & Mitigation
Because cutaneous lichen planus (CLP) is driven by an overactive local immune response, therapies are designed to calm the cellular “neighborhood watch team,” soothe the intense itch, and allow the skin to restore its natural balance [1, 14]. To help you navigate this section, it helps to understand two important medical words:
- Refractory: This describes a condition or a rash that is stubborn and does not get better, even after trying gold-standard and everyday medical treatments [14].
- Off-label: This means a doctor prescribes a medication that is approved for one condition because available evidence or clinical experience supports its use for a different condition, even though that use is not included in the medication’s official approved labeling.
Gold-Standard & First-Line Treatments
Our absolute gold-standard treatments are applied directly to the skin, which means they tend to have fewer whole-body side effects than oral medications [14, 15].
Topical Corticosteroids (Creams and Ointments)
For localized areas, ultra-potent topical corticosteroids, such as Clobetasol Propionate 0.05% ointment, are the first line of defense [1, 14]. When you apply these directly to the active bumps, they act like a targeted cooling blanket. They turn down the volume on chemical immune signals and rapidly halt the itch [1].
Oral Corticosteroids (Pills)
When CLP is severe, rapidly spreading, or covers a massive portion of the body, doctors may pivot to a short course of oral systemic corticosteroids, such as Prednisone [1, 14]. These pills provide a rapid “reset” button to calm your entire body’s immune flare [1].
Second-Line & Systemic Standard Treatments
If creams are not enough, doctors look to treatments that work slightly deeper or cover larger areas of the skin.
Phototherapy (Medical Light Therapy)
Phototherapy uses specific, safe wavelengths of ultraviolet light called Narrow-Band UVB (NB-UVB) [14, 19]. You can receive this in a clinic inside a specialized medical light cabinet 2 to 3 times per week, or use a specialized home device prescribed by your doctor. Systematic reviews show that NB-UVB can actually outperform short courses of oral steroids in providing long-term clearance [19, 29].
Oral Retinoids (Vitamin A Derivatives)
For stubborn, refractory cases, doctors may prescribe oral retinoids, such as acitretin [1, 14]. This medication normalizes how your skin cells grow and shed, preventing the bumpy buildup [1, 15].
Other Systemic Immunomodulators
Medicines like hydroxychloroquine or methotrexate gently alter specific chemical pathways within your immune system to stop the attack on your skin [14, 15, 30].

AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
Experimental & Emerging Clinical Trials
The most exciting modern frontier in molecular dermatology involves Janus Kinase (JAK) Inhibitors [14, 21, 22, 31]. These advanced targeted medications—such as abrocitinib, tofacitinib, and baricitinib—are currently being used off-label for folks with refractory CLP who have tried all the gold-standard treatments without success [14, 31].
How JAK Inhibitors Work: The Tollbooth Analogy
Imagine your immune system’s inflammatory messages are cars trying to drive down a highway to your skin cells. JAK inhibitors act like a closed tollbooth on that highway. By blocking the signal inside the cell, they stop the inflammatory traffic from ever reaching your skin [21, 22].
A recent study shows a highly promising response, with over 83% of patients with severe, unyielding lichen planus achieving partial or complete clearance within weeks of starting targeted therapies like baricitinib [23]. While scientists are still conducting international clinical trials to secure formal, official approval, these innovations represent immense hope for the future [21, 22, 23, 31].
Reassuring Note: You are not locked into one path. There is no single “best” treatment for everyone. If a treatment does not work or causes side effects that disrupt your life, always tell your healthcare provider. There are many steps on this ladder, and new, gentler options are arriving every day. And, just to normalize things a bit more, many people require more than one therapy before finding the treatment plan that works best for them. You got this!
Building Your Multidisciplinary Care Team
Managing a chronic condition like cutaneous lichen planus sometimes requires a multidisciplinary care plan (a team of different healthcare professionals working together to look after your whole body and mind). Depending on how your condition behaves, you may want to loop in the following professionals:
- Your Primary Care Physician (PCP) Coordinates care, manages routine blood screenings (cholesterol, blood glucose, thyroid function), and monitors whole-body health.
- A Dermatologist The quarterback of your skin care who specializes exclusively in diagnosing and treating diseases of the skin, hair, and nails.
- A Mental Health Professional Therapist or Psychologist/Psychodermatologist who helps manage the emotional weight, anxiety, and impact on self-esteem associated with chronic skin conditions.
- A Sexual Health Counselor or Relationship Therapist Provides a safe, trauma-informed space to navigate vulnerable conversations regarding body image and intimacy.

Living with CLP: Holistic Adjuncts, Self-Care & Well-Being
While medical treatments work to control the underlying inflammation of cutaneous lichen planus (CLP), simple daily habits can help soothe itching, protect the skin barrier, and reduce additional irritation. These are generally good habits to adhere to for overall skin health.
Gentle Cleansing: Protect Your Skin Barrier
During an active flare, your skin barrier may be more sensitive and easier to irritate. Avoid heavily fragranced soaps, shower gels, and harsh cleansers, which can dry the skin and worsen itching.
Instead, choose a gentle, fragrance-free, soap-free cleanser or an emollient-based wash. Examples include:
- CeraVe Hydrating Body Wash
- Cetaphil Gentle Skin Cleanser
- Vanicream Gentle Body Wash
- La Roche-Posay Lipikar Wash AP+
- Bioderma Atoderm Cleansing Oil
Some thick, fragrance-free emollient creams can also be used as soap substitutes. Apply a small amount to damp skin and gently rinse it away with lukewarm water.
You do not need to scrub your skin to get it clean. During an active flare, avoid loofahs, exfoliating gloves, rough washcloths, body scrubs, and vigorous towel drying. Friction and skin injury can sometimes trigger new lichen planus lesions through something called the Koebner phenomenon, where new lesions develop in areas where the skin has been scratched, rubbed, or injured.
Use your hands to wash your skin, keep showers comfortably warm rather than hot, and gently pat rather than rub your skin dry. Trust me, I know this is easier said than done. I (Jaclyn) love a super-hot shower or bath, even though I know it’s not the greatest for skin health.
Soothe the Itch Without Scratching
The itch of cutaneous lichen planus can be difficult to ignore, and scratching often provides temporary relief. Unfortunately, scratching can further irritate the skin, which may lead to more itching, creating an itch-scratch cycle that can feel difficult to escape.
For additional relief, you can try:
- applying a clean, cool, damp compress to itchy areas;
- taking a lukewarm bath with colloidal oatmeal;
- keeping fingernails short and smooth to reduce accidental skin damage;
- wearing soft, breathable fabrics when possible;
- avoiding overheating (when possible), especially if heat or sweating worsens your itch; and
- using your prescribed anti-inflammatory treatment as directed rather than relying on scratching for relief.

If itching is severe enough to repeatedly wake you from sleep or interfere with daily life, tell your healthcare provider. Severe itching deserves treatment and may be a sign that your CLP needs better inflammatory control.
Moisturize Regularly
After showering and/or bathing, apply a thick, fragrance-free moisturizer while your skin is still slightly damp. You may have heard this called the “three-minute rule”: moisturizing soon after bathing helps trap some of that water in the outer layer of your skin before it evaporates.
Look for creams or ointments rather than thin, heavily fragranced lotions. Helpful options may include:
- CeraVe Moisturizing Cream, which contains ceramides;
- La Roche-Posay Lipikar AP+M Triple Repair Moisturizing Cream;
- Vanicream Moisturizing Cream;
- Aveeno Eczema Therapy or Dermexa, which contain colloidal oatmeal; or
- plain petroleum jelly, particularly for very dry or friction-prone areas.
There is no single “best” moisturizer for everyone. The best choice is one that feels comfortable, does not sting or irritate your skin, and that you are happy to use consistently.
If a product burns, stings, or seems to make your skin worse, stop using it and try a simpler fragrance-free option. Products marketed as “natural” or “clean” are not automatically gentler. Essential oils, botanical extracts, and fragrances can still irritate sensitive skin.
Reduce Friction and Skin Injury
Because of the Koebner phenomenon, protecting your skin from repeated irritation may help reduce unnecessary irritation during an active flare.
When possible:
- choose loose, soft clothing over tight or rough fabrics;
- remove clothing tags that repeatedly rub against affected areas;
- avoid scratching, picking, or aggressively exfoliating lesions;
- use care when shaving over active lesions; and
- protect areas exposed to repeated pressure or friction.
You do not need to become afraid of normal movement or everyday activities. The goal is simply to recognize and reduce repeated, avoidable irritation when your skin is already inflamed.
Self-Care Supports Treatment, It Does Not Replace It
Moisturizers, gentle cleansers, cool compresses, and colloidal oatmeal can make your skin feel significantly more comfortable, but they do not treat the underlying immune-driven inflammation of active cutaneous lichen planus.
Think of moisturizer as helping repair and protect the “brick wall” of your skin barrier, while your prescribed medication works on the inflammation happening within that wall. Both may be helpful, but they have different jobs.
If you use both a prescribed topical medication and a moisturizer, ask your healthcare provider or pharmacist how they would like you to space or layer the products so that you do not accidentally dilute or spread your medication beyond the intended treatment area.
Most importantly, self-care should feel supportive, not overwhelming. You do not need an expensive shelf full of specialized skincare products to care for CLP. A simple routine—a gentle cleanser, a moisturizer your skin tolerates, your prescribed treatment, and strategies to reduce itching and friction—is often enough. My personal philosophy with all of my chronic health conditions is to follow my evidence-based treatment plan, and keep lifestyle and adjunct support as cheap and simple as I can.
Your skin may have different needs during an active flare than it does once the inflammation settles. Learning what helps your skin feel comfortable is part of managing CLP, and your routine can be adjusted over time with your healthcare team.
The Emotional Side of Cutaneous Lichen Planus
Cutaneous lichen planus (CLP) does not affect only the surface of your skin. It can also affect how you sleep, dress, socialize, work, relax, and feel about your body.
If you have recently been diagnosed, you may already be noticing this hidden burden. Perhaps you check your skin more often than you used to. You may choose clothing based on what covers the marks, worry that new bumps are appearing, or feel exhausted after another night of itching.
Sometimes, the hardest part is simply feeling as though you can never forget about your skin.
Research shows that lichen planus can substantially reduce quality of life. Studies have also found higher rates of depression and anxiety among people living with lichen planus than among people without the condition.[24, 25, 26, 27]
Understanding this emotional burden does not make CLP “all in your head.” CLP is a real immune-mediated inflammatory disease. It simply recognizes that living with visible changes, discomfort, uncertainty, and disrupted sleep can affect the whole person.
Navigating Grief and Changes in Identity
When a skin condition changes your appearance, it is understandable to feel a sense of grief.
Your skin is part of how you recognize yourself and move through the world. When it changes unexpectedly, you may look in the mirror and think, This does not look like me. You may miss wearing certain clothes without planning around your skin. You may remember when getting dressed, going swimming, dating, or being touched did not require extra thought.
There can be grief in that.
This does not mean you are vain, dramatic, or coping badly. You are adjusting to a medical condition that may have appeared suddenly and that you may never have heard of before your diagnosis.
Some days, you may feel hopeful because you finally have an explanation. On other days, you may feel angry that you need treatment at all. You can feel relieved to have a diagnosis and still feel frightened by it.
Both feelings can exist at the same time.
Healing does not require you to feel positive every day. Sometimes it begins with acknowledging, This is difficult, and I deserve support while I adjust.
Understanding the Skin–Stress Cycle

AI disclosure: This figure was created with AI assistance for educational and illustrative purposes. It may not precisely reflect real-world anatomy, clinical presentation, or disease features and may contain inaccuracies.
Stress does not mean that you caused your lichen planus. It is also not accurate to say that simply relaxing will make CLP disappear.
However, chronic itching can increase distress, while distress and poor sleep can make itching feel even harder to tolerate. Scratching may then injure already inflamed skin and continue the itch–scratch cycle.[24, 26, 28]
Treating the skin remains essential. Supporting sleep, mood, and coping can help make the experience more manageable alongside medical care.
What the Research Shows
Quality of Life
In one study, lichen planus affected quality of life in 78% of participants. People with cutaneous involvement had greater skin-related quality-of-life impairment than participants without skin involvement.[24]
The Dermatology Life Quality Index, or DLQI, is a questionnaire clinicians and researchers use to measure how a skin condition affects areas such as symptoms, clothing, work, relationships, and social activities. It does not measure how “strong” someone is. It measures the practical burden of living with a skin disease.
Emotional Well-Being
In the same study, 29% of participants reported mild-to-moderate depressive symptoms, while 6% reported severe symptoms.[24]
A systematic review and meta-analysis found signs of depression in approximately 27% of people with lichen planus and signs of anxiety in approximately 28%. Compared with people without lichen planus, those living with the condition had higher odds of experiencing both.[25]
These numbers describe groups, not your future. Having CLP does not mean that you will develop depression or anxiety. They simply show that emotional health deserves attention as part of complete lichen planus care.
Everyday Disruptions
Qualitative research—studies in which researchers listen closely to patients’ experiences—shows that CLP can affect much more than physical comfort.
People have described:
- persistent itching and burning;
- frustration and worry;
- embarrassment about visible lesions;
- difficulty sleeping or concentrating;
- changes in clothing choices;
- avoidance of social situations; and
- effects on physical closeness and intimacy.[26]
These experiences are not “minor” simply because they cannot be measured through a blood test or seen during a skin examination.
A Reassuring Reminder
Low mood, sadness, anger, or self-consciousness are not personal failings. They can be understandable responses to living with an uncomfortable and visible medical condition.
You do not have to wait until you are in crisis to ask for help.
Consider speaking with a healthcare professional when emotional distress:
- lasts for several weeks;
- interferes with sleep, work, relationships, or daily activities;
- causes you to withdraw from people or activities you value;
- makes you feel hopeless; or
- feels too heavy to manage alone.

Support may come from your primary care provider, dermatologist, counsellor, psychologist, peer-support organization, or another professional you trust.
Sometimes it helps to hear from someone who understands.
Melanie shares her experience living with lichen planus and lichen sclerosus, including diagnosis, pain, mental health, and finding hope.
Read or Watch Melanie’s Story →Body Confidence, Sexuality, and Intimacy
Even when lichen planus affects only external skin and does not involve the genitals, it may still influence how you feel about intimacy.
You may worry that a partner will notice the marks. You may hesitate to undress or avoid touch because your skin feels tender or itchy. You may also worry that someone will mistakenly believe the rash is contagious or caused by poor hygiene.
CLP is not contagious. It cannot be passed to another person through touching, kissing, sharing a bed, or sexual contact.
You also did not develop CLP because you failed to wash properly or take care of your skin.
Research on patient experiences shows that visible lesions, itching, pain, and uncertainty can affect social participation and intimacy.[26] Broader studies of lichen planus have also found increased rates of anxiety and depression, which can affect energy, confidence, interest in enjoyable activities, and the desire for closeness.[25, 27]
That does not mean every change in desire or intimacy is permanent. Your needs may shift as the disease becomes better controlled and as you rebuild trust in your body.
Talking with a Partner
If you have a partner, giving them simple, accurate information can reduce fear and misunderstanding.
You might say:
You do not need to explain everything at once. A helpful conversation may simply include:
- what CLP is;
- what it is not;
- which areas are uncomfortable;
- what kinds of touch feel safe;
- what you need during a flare; and
- how your partner can support you without trying to “fix” everything.
Feeling believed and understood can reduce some of the isolation that comes with chronic skin disease.
Redefining Intimacy
During a flare, it may help to broaden what intimacy means.
Closeness might include:
- affectionate touch on comfortable areas;
- holding hands;
- cuddling or resting together;
- sharing a meaningful conversation;
- laughing together;
- giving a massage on unaffected skin; or
- simply being present with one another.

On some days, you may want physical closeness. On others, your body may need more space. Both are valid.
Changing how you connect during a flare is not “giving up.” It is adapting in a way that respects your body and protects your relationship.
Most importantly, you are still you.
Your skin may look or feel different right now. You may still be learning what this diagnosis means. But CLP does not make you less attractive, less worthy of touch, or less deserving of love, intimacy, and compassionate care.
The goal is not to force yourself to love every change. It is to build a relationship with your body that makes room for patience, honesty, and kindness—even on difficult days.
Barriers to Care, Treatment, and Research in Lichen Planus: Community Survey
Change requires both community voice and evidence.
If you are living with lichen planus, we invite you to take part in an important survey designed to better understand the real-world challenges people face in accessing care and participating in research. This work is being conducted in partnership with an international pharmaceutical organization to help ensure that patient experiences directly inform future care, resources, and clinical trial design.
Why We Are Doing the Survey
The survey explores areas such as time to diagnosis, barriers to care (including work, childcare, travel, cost, and language), the quality and clarity of information provided, and whether people of different ages, genders, racial or ethnic backgrounds, and languages feel represented in research and care. Each response helps transform lived experience into actionable data to support the development of clearer educational resources, improve access to knowledgeable providers, and expand inclusive clinical trials.
Eligibility
The survey takes approximately 35 minutes to complete and can be done anonymously. Participation is open to individuals aged 18 and older who are based in the United States and have a diagnosis of lichen planus affecting the skin, mouth, or genital areas. To ensure data quality, participants should not have completed another lichen planus survey within the past four weeks.
If you have questions about privacy, please contact: support@lssupportnetwork.org
We also encourage you to share this survey with others in your community or support networks. The more voices included, the stronger the foundation for change.
Conclusion
Living with cutaneous lichen planus can be a challenging and uncertain journey, but you do not have to navigate it alone. From understanding the underlying immune mechanisms and exploring evidence-based treatments to supporting your emotional well-being and daily skin health, knowledge is your most powerful tool. While managing a chronic condition takes patience, ongoing research and targeted therapies continue to open new doors for better care and long-term relief.
Want the broader picture?
Return to the comprehensive LP guide to explore other subtypes, treatment pathways, and whole-body considerations.
Visit the Comprehensive Lichen Planus Overview →Works Cited
References correspond to the numbered citations throughout this page.
- Boch, K., Langan, E. A., Kridin, K., Zillikens, D., Ludwig, R. J., & Bieber, K. (2021). Lichen planus. Frontiers in Medicine, 8, 737813. https://doi.org/10.3389/fmed.2021.737813
- Arnold, D. L., Syed, H. A., & Krishnamurthy, K. (2024). Lichen planus. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK526126/
- Le Cleach, L., & Chosidow, O. (2012). Clinical practice: Lichen planus. The New England Journal of Medicine, 366(8), 723–732. https://doi.org/10.1056/NEJMcp1103641
- Vičić, M., Hlača, N., Kaštelan, M., Brajac, I., Sotošek, V., & Prpić Massari, L. (2023). Comprehensive insight into lichen planus immunopathogenesis. International Journal of Molecular Sciences, 24(3), 3038. https://doi.org/10.3390/ijms24033038
- Shao, S., Tsoi, L. C., Sarkar, M. K., Xing, X., Xue, K., Uppala, R., Berthier, C. C., Zeng, C., Patrick, M., Billi, A. C., Fessler, M. B., Kahlenberg, J. M., Perl, A., Harms, P. W., Xie, X., Cheng, Q., Weinberg, J. M., Ma, F., Chen, L., & Gudjonsson, J. E. (2019). IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Science Translational Medicine, 11(511), eaav7561. https://doi.org/10.1126/scitranslmed.aav7561
- Ying, J., Xiang, W., Qiu, Y., & Zeng, X. (2020). Risk of metabolic syndrome in patients with lichen planus: A systematic review and meta-analysis. PLOS ONE, 15(8), e0238005. https://doi.org/10.1371/journal.pone.0238005
- Lai, Y. C., Yew, Y. W., & Schwartz, R. A. (2016). Lichen planus and dyslipidemia: A systematic review and meta-analysis of observational studies. International Journal of Dermatology, 55(5), e295–e304. https://doi.org/10.1111/ijd.13234
- Arias-Santiago, S., Buendía-Eisman, A., Aneiros-Fernández, J., Girón-Prieto, M. S., Gutiérrez-Salmerón, M. T., García Mellado, V., & Naranjo-Sintes, R. (2011). Cardiovascular risk factors in patients with lichen planus. The American Journal of Medicine, 124(6), 543–548. https://doi.org/10.1016/j.amjmed.2010.12.025
- Mallah, N., Varela-Centelles, P. I., Seoane-Romero, J., & Takkouche, B. (2022). Diabetes mellitus and oral lichen planus: A systematic review and meta-analysis. Oral Diseases, 28(8), 2100–2109. https://doi.org/10.1111/odi.13927
- Li, D., Li, J., Li, C., Chen, Q., & Hua, H. (2017). The association of thyroid disease and oral lichen planus: A literature review and meta-analysis. Frontiers in Endocrinology, 8, 310. https://doi.org/10.3389/fendo.2017.00310
- Sigurgeirsson, B., & Lindelöf, B. (1991). Lichen planus and malignancy: An epidemiologic study of 2071 patients and a review of the literature. Archives of Dermatology, 127(11), 1684–1688. https://doi.org/10.1001/archderm.1991.01680100084009
- Knackstedt, T. J., Collins, L. K., Li, Z., Yan, S., & Samie, F. H. (2015). Squamous cell carcinoma arising in hypertrophic lichen planus: A review and analysis of 38 cases. Dermatologic Surgery, 41(12), 1411–1418. https://doi.org/10.1097/DSS.0000000000000565
- Sagi, L., & Trau, H. (2011). The Koebner phenomenon. Clinics in Dermatology, 29(2), 231–236. https://doi.org/10.1016/j.clindermatol.2010.09.014
- Tekin, B., Xie, F., & Lehman, J. S. (2024). Lichen planus: What is new in diagnosis and treatment? American Journal of Clinical Dermatology, 25(5), 735–764. https://doi.org/10.1007/s40257-024-00878-9
- Solimani, F., Forchhammer, S., Schloegl, A., Ghoreschi, K., & Meier, K. (2021). Lichen planus—A clinical guide. Journal der Deutschen Dermatologischen Gesellschaft, 19(6), 864–882. https://doi.org/10.1111/ddg.14565
- Güngör, Ş., Topal, İ. O., & Göncü, E. K. (2015). Dermoscopic patterns in active and regressive lichen planus and lichen planus variants: A morphological study. Dermatology Practical & Conceptual, 5(2), 45–53. https://doi.org/10.5826/dpc.0502a06
- De, D., Jain, S., Dev, A., & Chatterjee, D. (2024). Oral lichen planus-like lesions in skin of color: A review. International Journal of Dermatology, 63(11), 1503–1512. https://doi.org/10.1111/ijd.17341
- Harvey, N. T., Chan, J., & Wood, B. A. (2017). Skin biopsy in the diagnosis of inflammatory skin disease. Australian Family Physician, 46(5), 283–288.
- Atzmony, L., Reiter, O., Hodak, E., Gdalevich, M., & Mimouni, D. (2016). Treatments for cutaneous lichen planus: A systematic review and meta-analysis. American Journal of Clinical Dermatology, 17(1), 11–22. https://doi.org/10.1007/s40257-015-0160-6
- Hodgens, A., & Sharman, T. (2023). Corticosteroids. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554612/
- Alsayb, M. A. (2025). Innovations in immunotherapy for autoimmune diseases: Recent breakthroughs and future directions. Frontiers in Immunology, 16, 1647066. https://doi.org/10.3389/fimmu.2025.1647066
- Greco, R., Alexander, T., Del Papa, N., Ljungman, P., Onida, F., Cadranel, J., et al. (2024). Innovative cellular therapies for autoimmune diseases: Expert-based position statement and clinical practice recommendations from the EBMT Practice Harmonization and Guidelines Committee. EClinicalMedicine, 69, 102476. https://doi.org/10.1016/j.eclinm.2024.102476
- Hwang, A. S., Kechter, J. A., Do, T. H., Duong, C., Ahmed, N., Ahn, D., Sharma, R., Bhatt, S., Kim, J. H., Tam, D., Lam, C. D., Vega Bautista, S., Zhang, C., Nagler, A. R., Peris, K., Alavi, A., Villablanca, E., Wei, M. L., Simpson, E. L., & Wang, E. A. (2025). Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells. Journal of Clinical Investigation, 135(2), e179436. https://doi.org/10.1172/JCI179436
- Fiocco, Z., Kupf, S., Patzak, L., Kämmerer, T., Pumnea, T., French, L. E., & Reinholz, M. (2021). Quality of life and psychopathology in lichen planus: A neglected disease burden. Acta Dermato-Venereologica, 101(12), adv00619. https://doi.org/10.2340/actadv.v101.442
- Jalenques, I., Lauron, S., Almon, S., Pereira, B., D’Incan, M., & Rondepierre, F. (2020). Prevalence and odds of signs of depression and anxiety in patients with lichen planus: Systematic review and meta-analyses. Acta Dermato-Venereologica, 100(18), adv00330. https://doi.org/10.2340/00015555-3660
- Mahon-Smith, A., Clifford, M., Batish, A., Sharp, R., Panter, C., Naujoks, C., Schruf, E., Compagno, N., & Moreno, S. G. (2023). Patient experience of lichen planus: A qualitative exploration of signs, symptoms, and health-related quality of life impacts. Dermatology and Therapy, 13(9), 2001–2017. https://doi.org/10.1007/s13555-023-00968-2
- Hsu, D. Y., Chien, W. C., Chung, C. H., Chiu, K. C., Li, T. I., Kung, L. Y., & Tzeng, N. S. (2022). Risk of anxiety and depression in patients with lichen planus: A nationwide population-based study. Journal of Affective Disorders, 300, 255–262. https://doi.org/10.1016/j.jad.2021.12.127
- Weisshaar, E., Szepietowski, J. C., Dalgard, F. J., Garcovich, S., Gieler, U., Giménez-Arnau, A. M., Lambert, J., Leslie, T., Mettang, T., Misery, L., Şavk, E., Streit, M., Tschachler, E., Wallengren, J., & Ständer, S. (2019). European S2k guideline on chronic pruritus. Acta Dermato-Venereologica, 99(5), 469–506.
- Iraji, F., Faghihi, G., Asilian, A., Siadat, A. H., Larijani, F. T., & Akbari, M. (2011). Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: A randomized clinical trial. Journal of Research in Medical Sciences, 16(12), 1578–1582. https://pmc.ncbi.nlm.nih.gov/articles/PMC3434899/
- Fatemi Naeini, F., Saber, M., Asilian, A., & Hosseini, S. M. (2017). Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: A randomized clinical trial. International Journal of Preventive Medicine, 8, 37. https://doi.org/10.4103/ijpvm.IJPVM_156_17
- Abduelmula, A., Bagit, A., Mufti, A., Yeung, K. C. Y., & Yeung, J. (2023). The use of Janus kinase inhibitors for lichen planus: An evidence-based review. Journal of Cutaneous Medicine and Surgery, 27(3), 271–276. https://doi.org/10.1177/12034754231156100
- Colafemina, A. C. E., Pedroso, C. M., Perez-de-Oliveira, M. E., Normando, A. G. C., France, K., Gomes, R. T., Napimoga, M. H., Lopes, M. A., & Santos-Silva, A. R. (2026). Malignant transformation in extraoral lichen planus: A systematic review and meta-analysis in the context of the risk in oral lichen planus. Dentistry Journal, 14(4), 217. https://doi.org/10.3390/dj14040217
